| 401 |
CB 1 cannabinoid receptor-G protein association: a possible mechanism for differential signaling |
2002 |
| 402 |
Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
|
2002 |
| 403 |
Does the dihydropyridines modify the anticonvulsant action of sodium valproate? |
2001 |
| 404 |
A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice |
2001 |
| 405 |
A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. |
2001 |
| 406 |
Effect of Lidocaine on the anticonvulsant properties of valproic acid against convulsions elicited by pentylenetetrazol in mice. |
2001 |
| 407 |
Modulation of the anticonvulsant action of valproic acid by verapamil against pertylentetrazol-induced seizures in mice. |
2001 |
| 408 |
N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice |
2001 |
| 409 |
Pharmacotherapy of rheumatoid arthritis: an overview
|
2001 |
| 410 |
The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest. |
2001 |